This is a single-arm, single-center, prospective observational study. It uses offline PET/CT to verify and quantify the range accuracy of hypofractionated proton radiotherapy for postoperative breast cancer. The correlation between range error and clinical toxicities (radiation pneumonitis, rib fracture) will be analyzed. A PET signal-proton range correlation model will be established using Monte Carlo simulation to provide evidence for optimizing proton therapy planning.
Study Type
OBSERVATIONAL
Enrollment
30
Offline PET/CT scan performed after proton therapy to verify range accuracy; no therapeutic intervention
Proton beam range accuracy verified by offline PET/CT
Quantify the range accuracy of hypofractionated proton radiotherapy for breast cancer using offline PET/CT imaging
Time frame: During proton radiotherapy (at the time of offline PET/CT scanning)
Correlation between range error and radiation pneumonitis
Evaluate the correlation between proton range error measured by offline PET/CT and the incidence of radiation pneumonitis
Time frame: Up to 24 months after completion of proton radiotherapy
Correlation between range error and rib fracture
Evaluate the correlation between proton range error measured by offline PET/CT and the incidence of rib fracture
Time frame: Up to 24 months after completion of proton radiotherapy
Correlation between range error and lung dosimetric parameters
Analyze the correlation between proton range error and lung V5, V10, V20
Time frame: During proton radiotherapy
Correlation between range error and rib dosimetric parameters
Analyze the correlation between proton range error and rib Dmax, V30
Time frame: During proton radiotherapy
Performance of PET signal-proton range prediction model
Establish and evaluate the PET signal-proton range quantitative model using Monte Carlo simulation
Time frame: During proton radiotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.